FDA Inspection
davAgen Pharmaceuticals LLCdavAgen Pharmaceuticals LLC – FDA Inspection, Feb 27, 2012
Record Details
This FDA Inspection record concerns davAgen Pharmaceuticals LLC, with an inspection on February 27, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- davAgen Pharmaceuticals LLC
- Inspection Date
- February 27, 2012
- Product Type
- Drugs
View Company Profile
ID · 59d27c2f-6c0e-4940-a4c8-388e4fc20724
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 768767
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
- 21 CFR 211.65(a)Equipment construction - reactive surfaces
- 21 CFR 211.194(b)Test method modification records do not include
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.